A Study of the Systemic Absorption of Once Daily MOB015B When Applied for 28 Days in Subjects With Moderate to Severe Onychomycosis of the Toenails.
Phase of Trial: Phase I
Latest Information Update: 07 May 2018
At a glance
- Drugs Terbinafine (Primary)
- Indications Onychomycosis
- Focus Pharmacokinetics
- Sponsors Moberg Pharma
- 02 May 2018 Status changed from active, no longer recruiting to completed.
- 05 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 23 Jan 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Apr 2018.